• Synthetic Viability with ERCC1 Deficiency in Lung Cancer: Me

  2026-06-12

  This article analyzes a landmark study that reveals how p53 status modulates synthetic viability and DNA repair pathways in ERCC1-deficient lung cancer cells following interstrand crosslink (ICL) damage. The findings highlight the importance of genetic context in predicting platinum chemotherapy responses and inform future strategies for exploiting DNA repair vulnerabilities in cancer.

• BMN 673 (Talazoparib): Precision Tool for DNA Repair Deficie

  2026-06-12

  BMN 673 (Talazoparib) stands apart as a next-generation, ultra-potent PARP1/2 inhibitor, enabling selective targeting of homologous recombination deficient cancer models. Its unique PARP-DNA complex trapping and synergy with DNA-damaging agents empower advanced assay workflows and translational research, with APExBIO ensuring reliable access for experimental reproducibility.

• A20 Modulates Oxidized Self-DNA Inflammation in Acute Kidney

  2026-06-11

  The referenced study elucidates how the ubiquitin-editing enzyme A20 mitigates inflammation in acute kidney injury (AKI) by modulating oxidized self-DNA-induced activation of the cGAS-STING pathway and NLRP3 inflammasome. These findings advance our mechanistic understanding of sterile inflammation in AKI and highlight new molecular targets for intervention.

• BAPTA-AM in Calcium-Dependent BDNF Release: Advanced Assay S

  2026-06-11

  Explore how BAPTA-AM, a leading cell-permeable calcium chelator, enables precision control of calcium-dependent BDNF localization and release in neuromuscular synapse formation. This article offers advanced assay guidance and unique mechanistic insights absent from standard protocol guides.

• Applied Workflows with (-)-Norepinephrine (+)-bitartrate

  2026-06-10

  (-)-Norepinephrine (+)-bitartrate from APExBIO enables reproducible modeling of adrenergic receptor signaling in cardiovascular and cardiomyopathy research. This guide delivers advanced experimental workflows, protocol optimization, and troubleshooting strategies that help translate bench findings into robust, high-impact outcomes.

• Octanoic Acid Nutrition Modulates Macrophage Polarization vi

  2026-06-10

  This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by shifting intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 pathway. The work clarifies mechanistic links between dietary fatty acids, nuclear receptor signaling, and immune balance, providing a framework for nutritional and pharmacological modulation of inflammation.

• Baicalin Methyl Ester in LPS-Induced Intestinal Barrier Rese

  2026-06-09

  Baicalin methyl ester, an esterified derivative of baicalin, enables precise, reproducible protection against LPS-induced intestinal barrier damage by modulating the P65/TNF-α/MLCK/ZO-1 pathway. This article translates advanced molecular findings into actionable experimental workflows, troubleshooting strategies, and protocol enhancements for intestinal inflammation research.

• 2'3'-cGAMP (Sodium Salt): Applied Workflows for STING Pathwa

  2026-06-09

  2'3'-cGAMP (sodium salt) is the gold standard for dissecting STING-mediated innate immune responses, offering unmatched water solubility and nanomolar STING binding affinity. This article translates recent research breakthroughs into actionable protocols, troubleshooting strategies, and advanced use-cases for immunology, cancer, and antiviral studies.

• Tomivosertib: Applied MNK1 Inhibitor Workflows & Troubleshoo

  2026-06-08

  Tomivosertib enables rapid, selective MNK1/2 inhibition for dissecting translation control and neuronal excitability in research models. This guide distills cutting-edge use-cases, protocol parameters, and troubleshooting strategies, grounded in recent evidence and real-world experimental demands.

• SR-202: Unraveling PPARγ Antagonism for Next-Gen Translation

  2026-06-08

  This article delivers a mechanistic and strategic deep-dive into SR-202, a highly selective PPARγ antagonist, as a transformative tool in insulin resistance, obesity, and immunometabolic research. By integrating mechanistic insight with translational guidance, it connects the latest evidence on macrophage polarization, highlights protocol best practices, and positions SR-202 as an indispensable asset for researchers targeting metabolic and inflammatory disorders.

• Proteoform-Specific Drug Interactions in Native Cell Signali

  2026-06-07

  This article analyzes a landmark study that directly characterizes proteoform-specific interactions within native membrane environments using advanced mass spectrometry. The findings offer critical insight into the complexity of protein modifications and their implications for targeted drug development, including off-target effects of cGMP-specific phosphodiesterase type 5 inhibitors.

• CDC42 Regulates Intestinal Stem Cell Fate via YAP-EGF-mTOR A

  2026-06-06

  The reference study uncovers how CDC42-mediated apical-basal polarity orchestrates the transition from intestinal stem cells to transit amplifying cells through a YAP-EGF-mTOR signaling cascade, independent of canonical Wnt pathways. These findings refine our understanding of gastrointestinal epithelial homeostasis, providing a mechanistic framework for stem cell fate regulation and crypt proliferation.

• (-)-Norepinephrine (+)-bitartrate in Cardiomyopathy Models

  2026-06-05

  (-)-Norepinephrine (+)-bitartrate empowers cardiovascular research with nanomolar precision, enabling robust animal models of cardiomyopathy and vascular response quantification. Leverage new insights on dose-response and hemodynamic indices to optimize experimental rigor and reproducibility.

• Triamcinolone: Technical Guidance for Glucocorticoid Assays

  2026-06-05

  Triamcinolone is a synthetic glucocorticoid agonist designed for research applications requiring precise manipulation of glucocorticoid signaling. It is best suited for in vitro studies focusing on inflammation, immunology, and receptor pathway analysis, but is not intended for diagnostic or clinical use.

• 4-Methylumbelliferyl-β-D-Glucopyranoside in Lysosomal Enzyme

  2026-06-04

  4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) sets the gold standard for sensitive, scalable β-glucosidase and β-glucocerebrosidase activity assays in both discovery and translational research. Its precise fluorescence readout, robust solubility profile, and proven track record in recent mRNA-based Gaucher disease models make it a versatile tool for optimizing lysosomal function studies.

9187 records 1/613 page Next 12345 下5页 Last page